Short-term variations in enterolactone in serum, 24-hour urine, and spot urine and relationship with enterolactone concentrations.
Stumpf
Katariina
K
Folkhälsan Research Center, Institute for Preventive Medicine, Nutrition and Cancer, Biomedicum, PB 63, University of Helsinki, FIN-00014 Helsinki, Finland. katariina.stumpf@helsinki.fi
Adlercreutz
Herman
H
D015107:4-Butyrolactone / Q000031:analogs & derivatives* / Q000097:blood* / Q000652:urine*; D015415:Biomarkers / Q000032:analysis; D005260:Female; D015200:Fluoroimmunoassay; D006801:Humans; D017705:Lignans / Q000097:blood* / Q000652:urine*; D008297:Male; D013997:Time Factors
D015415:Biomarkers; D017705:Lignans; D015107:4-Butyrolactone; C029497:2,3-bis(3'-hydroxybenzyl)butyrolactone